Search Results 451-460 of 18358 for total bilirubin

1. Daratumumab in Cardiac HLA Desensitization Prior to Transplantation - Mayo Clinic

   - Total bilirubin < 1.5 x institutional upper limit normal (ULN) - AST/ALT < 2. 5 - 3x ULN (Options for patients with liver dysfunction may be available)

2. A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma - Mayo Clinic

   Must have total serum bilirubin ≤ 3 mg/dl; ≥ 18 years of age; Measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 ...

3. A Phase 1b/2a Multicenter, Open-Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CC-220 as Monotherapy and in Combination with Other Treatments in Subjects with Multiple Myeloma - Mayo Clinic

   Light chain multiple myeloma without measurable disease in serum or urine: serum ... Serum total bilirubin and alkaline phosphatase > 1.5 x ULN;; Subjects with ...

4. Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab and Pegylated Liposomal Doxorubicin as Treatment for Ovarian Cancer. (PROTA) - Mayo Clinic

   ... bilirubin ≤ULN for participants with total bilirubin levels >1.5 × ULN (excluding patients with Gilbert's Disease) ii. Aspartate Aminotransferase (AST) ...

5. A Study to Determine the Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies - Mayo Clinic

   Total bilirubin ≤ 1.5 × upper limit of normal (ULN) except subjects with documented Gilbert's syndrome who must have a baseline total bilirubin ≤ 3.0 mg/dL; ...

6. The ExTINGUISH Trial Of Inebilizumab In NMDAR Encephalitis (ExTINGUISH) - Mayo Clinic

   Total bilirubin > 1.5 × ULN (unless due to Gilbert's syndrome);; Platelet ... Total white blood count <2,500 cells/mm^3;; Total immunoglobulin < 600 mg ...

7. Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer - Mayo Clinic

   Total bilirubin =< 1.5 x institutional upper limit of normal (IULN) (except Gilbert's syndrome, who must have a total bilirubin < 3.0 mg/dL); Aspartate ...

8. A Study Comparing a Vaccine with or without an Autologous Tumor Lysate to Treat Stage III or IV Melanoma to Prevent Recurrence - Mayo Clinic

   Total bilirubin ≤ 1.5 ULN; ALT and AST ≤ 1.5 ULN. For women of child-bearing potential, agreement to use adequate birth control (abstinence, hysterectomy ...

9. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

   Total Bilirubin ≤1.5 × ULN. For subjects with known Gilbert's disease or similar syndrome with slow conjugation of bilirubin, total bilirubin ≤ 3.0 mg/dL ...

10. Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer - Mayo Clinic

    Bilirubin (total) ≤ 1.5 times upper limit normal (with exception of Gilberts syndrome); AST(SGOT), ALT(SGPT), and alkaline phosphatase ≤ 2 times the ...